Atosiban
CAT:
804-HY-17572-01
Size:
5 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
Atosiban
- CAS Number: 90779-69-4
- UNSPSC Description: Atosiban (RW22164; RWJ22164) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research[1].
- Target Antigen: Oxytocin Receptor; Vasopressin Receptor
- Type: Peptides
- Related Pathways: GPCR/G Protein
- Applications: Cancer-programmed cell death
- Field of Research: Endocrinology; Cancer; Cardiovascular Disease
- Assay Protocol: https://www.medchemexpress.com/Atosiban.html
- Solubility: DMSO : ≥ 16.67 mg/mL|H2O : 16.67 mg/mL (ultrasonic)
- Smiles: O=C([C@H](CSSCCC(N[C@@H](C1=O)CC2=CC=C(OCC)C=C2)=O)NC([C@@H](NC(C(NC([C@](N1)([H])[C@@H](C)CC)=O)[C@H](O)C)=O)CC(N)=O)=O)N(CCC3)[C@@H]3C(N[C@@H](CCCN)C(NCC(N)=O)=O)=O
- Molecular Weight: 994.19
- References & Citations: [1]Sanu O, et al. Critical appraisal and clinical utility of atosiban in the management of preterm labor.
 Ther Clin Risk Manag. 2010 Apr 26;6:191-9.|[2]Philip J Ryan, et al. Oxytocin-receptor-expressing Neurons in the Parabrachial Nucleus Regulate Fluid Intake. Nat Neurosci. 2017 Dec;20(12):1722-1733.Front Neurosci. 2021 Sep 10;15:723064.|J Pharm Biomed Anal. 2022: 115156.|J Pharm Biomed Anal. 11 December 2021, 114518.|Transl Psychiatry. 2024 May 25;14(1):208.
- Shipping Conditions: Blue Ice
- Clinical Information: Launched